Why Is Life Science Focused Bruker Stock Trading Higher On Friday? - Bruker ( NASDAQ:BRKR )
Q1 revenue estimated at $795-$800 million vs. $758.9 million consensus, marking 10-11% YoY growth. BEST segment sees high-teens organic revenue decline, while BSI grows mid-single digits. China's new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for ...
https://www.benzinga.com/general/health-care/25/04/44763100/why-is-life-science-focused-bruker-stock-trading-higher-on-friday